Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-22-019321
Filing Date
2022-10-05
Accepted
2022-10-05 17:20:29
Documents
7
Effectiveness Date
2022-10-05

Document Format Files

Seq Description Document Type Size
1 S-8 s-8.htm S-8 166612
2 EX-4.3 reta-ex4_3.htm EX-4.3 138610
3 EX-5.1 reta-ex5_1.htm EX-5.1 20702
4 EX-23.2 reta-ex23_2.htm EX-23.2 5083
5 EX-FILING FEES reta-exfiling_fees.htm EX-FILING FEES 28895
6 GRAPHIC img262233946_0.jpg GRAPHIC 2470
7 GRAPHIC img262233946_1.jpg GRAPHIC 2891
  Complete submission text file 0000950170-22-019321.txt   368544
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-267755 | Film No.: 221296507
SIC: 2834 Pharmaceutical Preparations